Otsuka, Click trial digital depression therapy with GoogleOtsuka and Click Therapeutics are working with Verily, the healthcare subsidiary of Google owners Alphabet, on a fully Share XOtsuka, Click trial digital depression therapy with Googlehttps://pharmaphorum.com/news/otsuka-click-trial-digital-depression-therapy-with-google/
Former CEO of Proteus reflects on the dramatic fall of ‘digital pill’ unicornThe US healthcare system’s focus on activity rather than value for money was behind the demise of Proteus Share XFormer CEO of Proteus reflects on the dramatic fall of ‘digital pill’ unicornhttps://pharmaphorum.com/news/former-ceo-of-proteus-reflects-on-the-dramatic-fall-of-digital-pill-unicorn/
UK biotech PhoreMost to work with Otsuka on gene therapy projectsBuilding on an R&D tie-up with an Indian stem cell institution last year, UK biotech PhoreMost has begun Share XUK biotech PhoreMost to work with Otsuka on gene therapy projectshttps://pharmaphorum.com/news/uk-biotech-phoremost-to-work-with-otsuka-on-gene-therapy-projects/
Abilify MyCite and innovating in digital healthpharmaphorum’s Paul Tunnah spoke with Otsuka Pharmaceutical’s North America Pharmaceutical Business president and CEO Kabir Nath about the Share XAbilify MyCite and innovating in digital healthhttps://pharmaphorum.com/views-analysis-digital/abilify-mycite-and-innovating-in-digital-health/
Eyeforpharma Barcelona 2019 roundupThis year’s eyeforpharma Barcelona conference might have seemed all doom and gloom at the outset, with many predicting Share XEyeforpharma Barcelona 2019 rounduphttps://pharmaphorum.com/digital/eyeforpharma-barcelona-2019-roundup/
Digital health round-up: Otsuka doubles down on digital mental health treatmentOtsuka seems to think it’s onto something by using digital tech to aid treatment of mental health disorders: Share XDigital health round-up: Otsuka doubles down on digital mental health treatmenthttps://pharmaphorum.com/views-analysis-digital/digital-health-round-up-otsuka-doubles-down-on-digital-mental-health-treatment/
Otsuka funds prescription therapy app for depressionOtsuka is once again betting on digital as a new avenue for depression treatment by collaborating with Click Share XOtsuka funds prescription therapy app for depressionhttps://pharmaphorum.com/news/otsuka-funds-app-depression/
Otsuka has high hopes for its ‘drug creation engine’ acquisitionOtsuka is paying $430 million for a US clinical-stage biotech company it hopes will act as a ‘drug Share XOtsuka has high hopes for its ‘drug creation engine’ acquisitionhttps://pharmaphorum.com/news/otsuka-biotech-visterra-hierotope/
Mental health startup NeuroFlow wins digital health challengeNeuroFlow, a startup company focused on technology to support people with mental health issues has won a digital Share XMental health startup NeuroFlow wins digital health challengehttps://pharmaphorum.com/news/mental-health-startup-neuroflow-wins-digital-health-challenge/
